Drug Susceptibility Testing of Mycobacterium Simiae: An Emerging Pathogen in Iran.

Introduction: Mycobacterium simiae is an emerging pathogen in Iran and little is known about drug susceptibility patterns of this pathogen.

Materials And Methods: Twenty-five clinical isolates of M. simiae from 80 patients with confirmed NTM pulmonary disease were included in this study.

Antibiotic therapy success rate in pulmonary Mycobacterium avium complex: a systematic review and meta-analysis.

: The incidence of Mycobacterium avium complex (MAC) pulmonary disease is increasing worldwide. We conducted a systematic review and meta-analysis to determine the treatment success rate of antibiotic therapy in MAC pulmonary disease and evaluate the effectiveness of aminoglycoside-containing regimens.: We searched literature between 1 January 1980 to 19 June 2019.